Sam Klempner(@KlempnerSam) 's Twitter Profileg
Sam Klempner

@KlempnerSam

GI medical oncologist focusing on stomach and esophageal cancer research at Massachusetts General Hospital, Harvard Medical School

ID:1086165456757477377

calendar_today18-01-2019 07:36:39

1,1K Tweets

3,4K Followers

651 Following

Follow People
Sam Klempner(@KlempnerSam) 's Twitter Profile Photo

Out online in parallel with Scott Kopetz presentation. Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer. Nataliya Uboha Rona Yaeger Tanios Bekaii-Saab, MD Cancer Discovery Marcia Cruz-Correa, MD, PhD aacrjournals.org/cancerdiscover…

account_circle
Mairead G McNamara(@MGMcNamara) 's Twitter Profile Photo

Was a pleasure to work on the Scientific Committee for Thanks to Sam Klempner for your leadership and to all for lively discussions and to ASCO for co-ordinating. Great to see Patrick Forde also.

Was a pleasure to work on the #HPB #OG Scientific Committee for #ASCO24 Thanks to @KlempnerSam for your leadership and to all for lively discussions and to @ASCO for co-ordinating. Great to see @FordePatrick also.
account_circle
Kohei shitara(@KoheiShitara) 's Twitter Profile Photo

Reporting association between whole-transcriptome sequencing and IHC. Reasonable concordance regarding HER2 and CLDN18.2 but not 100%. Need further analysis to clarify. OncoAlert
onlinelibrary.wiley.com/doi/full/10.11…

account_circle
Elizabeth McKenna(@ElizSMcKenna) 's Twitter Profile Photo

Now online in Cancer Discovery: Early Immune Remodeling Steers Clinical Response to Frontline Chemoimmunotherapy in Advanced Gastric Cancer - by minae an, Arnav Mehta, Byung Hoon Min, You Jeong Heo, Seung Tae Kim, Sam Klempner, Jeeyun Lee MD et al. doi.org/10.1158/2159-8…

Now online in @CD_AACR: Early Immune Remodeling Steers Clinical Response to Frontline Chemoimmunotherapy in Advanced Gastric Cancer - by @AnMinae, @arnavmehta3, Byung Hoon Min, You Jeong Heo, Seung Tae Kim, @KlempnerSam, @JeeyunM et al. doi.org/10.1158/2159-8…
account_circle
Sam Klempner(@KlempnerSam) 's Twitter Profile Photo

Happy to share latest international collaboration led by awesome Arnav Mehta minae an and others. Jeeyun Lee MD Cancer Discovery SU2Cscience

Early immune remodeling steers clinical response to frontline chemoimmunotherapy in advanced gastric. aacrjournals.org/cancerdiscover…

account_circle
Myriam Chalabi(@MyriamChalabi) 's Twitter Profile Photo

What a great start of 2024! Excited, happy and proud to share our latest work published today Nature Medicine on the PANDA trial: neoadjuvant atezo+chemo in pts with gastric/GEJ cancers followed by surgery. Some of the key findings below. 1/10 nature.com/articles/s4159…

What a great start of 2024! Excited, happy and proud to share our latest work published today #openaccess @NatureMedicine on the PANDA trial: neoadjuvant atezo+chemo in pts with gastric/GEJ cancers followed by surgery. Some of the key findings below. 1/10 nature.com/articles/s4159…
account_circle
Lorenzo Ferri MD PhD(@LFerri123) 's Twitter Profile Photo

Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial | Nature Medicine nature.com/articles/s4159…

account_circle
Kohei shitara(@KoheiShitara) 's Twitter Profile Photo

KEYNOTE-585 is published The Lancet Oncology as presented at . Pembro+chemo improved pathCR of but EFS was not statistically significant. MSI-H is distinguished population. Full results of Matterhorn awaited. OncoAlert ESMO - Eur. Oncology ASCO
thelancet.com/journals/lanon…

account_circle
Cancer Cell(@Cancer_Cell) 's Twitter Profile Photo

Online Now: Genomic alterations driving precancerous to cancerous lesions in esophageal cancer development dlvr.it/SzXrS4

Online Now: Genomic alterations driving precancerous to cancerous lesions in esophageal cancer development dlvr.it/SzXrS4
account_circle
Sam Klempner(@KlempnerSam) 's Twitter Profile Photo

Thankful for friends/colleagues/mentors like Jeeyun Lee MD. Leveraging ex-vivo system to interrogate exosomes in gastric cancer. month.

Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced GC
science.org/doi/10.1126/sc…

account_circle
Jason Westin, MD FACP(@Lymphoma_Doc) 's Twitter Profile Photo

The ASCO Leadership Development Program is excellent. Early-mid career Oncologists who want to accelerate their career growth should absolutely apply. Plus - you get to know current/future ASCO superstars!

account_circle
#TumorBoardTuesday(@TumorBoardTues) 's Twitter Profile Photo

🪚CLAUDIN 18.2 has been a topic of discussion, & there’s fresh & emerging treatments for

🇮🇪Join Sam Klempner Darren Cowzer on Sept 26 to explore further

🌍Dive into this global discussion at 8pm EDT / 1am IST

FREE 👉🏽integrityce.com/TBT2023

🪚CLAUDIN 18.2 has been a topic of discussion, & there’s fresh & emerging treatments for #GastricCancer 🇮🇪Join @KlempnerSam @CowzerDarren on #TumorBoardTuesday Sept 26 to explore further 🌍Dive into this global discussion at 8pm EDT / 1am IST FREE #CME👉🏽integrityce.com/TBT2023
account_circle
Lorenzo Ferri MD PhD(@LFerri123) 's Twitter Profile Photo

Annual Symposium on Upper Gastro-Intestinal Cancers- McGill University. Oct 28 in Montreal. Multidisciplinary and Multinational varied perspectives on esophageal and gastric cancer. Sam Klempner MarkvanBergeHenegouwen Suzanne Gisbertz and more X-less speakers. mcgill.ca/thoracic/event…

Annual Symposium on Upper Gastro-Intestinal Cancers- McGill University. Oct 28 in Montreal. Multidisciplinary and Multinational varied perspectives on esophageal and gastric cancer. @KlempnerSam @mivanbh @SSGisbertz and more X-less speakers. mcgill.ca/thoracic/event…
account_circle
The Lancet Gastroenterology & Hepatology(@LancetGastroHep) 's Twitter Profile Photo

New research - Reynolds et al - Trimodality therapy vs perioperative chemotherapy for locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: the Neo-AEGIS phase 3 trial

thelancet.com/journals/langa…

New research - Reynolds et al - Trimodality therapy vs perioperative chemotherapy for locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: the Neo-AEGIS phase 3 trial thelancet.com/journals/langa… #OncTwitter #GITwitter #EsoCSM
account_circle